4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001801
10% owner bought 50,000 shares at an average $4.72 ($235,824)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-01-25 | Purchase | +20,100 | $4.86 | $97,686 | 5,083,386 | D: show line 1 in the form |
| Cambrian BioPharma Inc 10% owner | 2022-01-26 | Purchase | +29,900 | $4.62 | $138,138 | 5,113,286 | D: show line 2 in the form |
| Open-market purchases · 50,000 sh · avg $4.72 · $235,824 | |||||||
Loading xslF345X03/doc1.xml…